163 related articles for article (PubMed ID: 28346771)
21. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
22. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma of the head and neck (HNSCC)--multi-modality treatment and impact on survival.
Chan GG; Tai BC; Liang S; Lim DT; Soo KC
Asian J Surg; 2002 Jan; 25(1):35-40. PubMed ID: 17585443
[TBL] [Abstract][Full Text] [Related]
24. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
25. Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Muzzi E; Trabalzini F; Gava A; Stellin M; Da Mosto MC
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1349-55. PubMed ID: 21258812
[TBL] [Abstract][Full Text] [Related]
26. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
27. Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic.
Light T; Rassi EE; Maggiore RJ; Holland J; Reed J; Suriano K; Stooksbury M; Tobin N; Gross N; Clayburgh D
Head Neck; 2017 Jun; 39(6):1106-1112. PubMed ID: 28370667
[TBL] [Abstract][Full Text] [Related]
28. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma.
Østhus AA; Aarstad AK; Olofsson J; Aarstad HJ
JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):14-20. PubMed ID: 23329087
[TBL] [Abstract][Full Text] [Related]
29. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
30. Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer.
Tribius S; Donner J; Pazdyka H; Münscher A; Gröbe A; Petersen C; Krüll A; Tennstedt P
Head Neck; 2016 Jul; 38(7):1058-65. PubMed ID: 26873810
[TBL] [Abstract][Full Text] [Related]
31. A New Approach to Survival Analysis of Head and Neck Squamous Cell Carcinoma.
Masoudi S; Montazeri SA; Pourdanesh F; Biglarian A; Kazemi M; Rahgozar M
Arch Iran Med; 2017 Aug; 20(8):503-510. PubMed ID: 28846014
[TBL] [Abstract][Full Text] [Related]
32. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
[TBL] [Abstract][Full Text] [Related]
34. Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantation.
Coordes A; Albers AE; Lenarz M; Seehofer D; Puhl G; Pascher A; Neuhaus R; Neuhaus P; Pratschke J; Andreou A
Head Neck; 2016 May; 38(5):707-14. PubMed ID: 25521431
[TBL] [Abstract][Full Text] [Related]
35. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
36. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
Tang C; Chan C; Jiang W; Murphy JD; von Eyben R; Colevas AD; Pinto H; Lee-Enriquez N; Kong C; Le QT
Head Neck; 2015 Mar; 37(3):386-92. PubMed ID: 24431011
[TBL] [Abstract][Full Text] [Related]
37. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
38. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of body mass index before treatment for head and neck cancer.
Takenaka Y; Takemoto N; Nakahara S; Yamamoto Y; Yasui T; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
Head Neck; 2015 Oct; 37(10):1518-23. PubMed ID: 24890618
[TBL] [Abstract][Full Text] [Related]
40. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
